BioGend Therapeutics Co Ltd

NEW
ROCO:6733 (Taiwan)   Ordinary Shares
NT$ 25.5 +0.10 (+0.39%) Sep 18
At Loss
P/B:
3.20
Market Cap:
NT$ 3.43B ($ 107.78M)
Enterprise V:
NT$ 2.59B ($ 81.58M)
Volume:
52.00K
Avg Vol (2M):
142.99K
Trade In:
Volume:
52.00K
At Loss
Avg Vol (2M):
142.99K

BioGend Therapeutics Co Ltd (ROCO:6733) Dividend

BioGend Therapeutics Co Ltd (ROCO:6733) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -6.5%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: ROCO:6733 Dividend

Does BioGend Therapeutics Co Ltd (ROCO:6733) pay a dividend?

BioGend Therapeutics Co Ltd (ROCO:6733) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't BioGend Therapeutics Co Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. BioGend Therapeutics Co Ltd has returned capital to shareholders via buybacks at a rate of -6.5% over the past 3 years.

What are dividend-paying alternatives to BioGend Therapeutics Co Ltd?

For dividend-paying alternatives in BioGend Therapeutics Co Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.